Features - Page 1

Investigator relations: Road to success for clinical trials 16 January, 2012 Identifying and selecting the right investigator has a significant impact on the success or failure of a clinical trial. In the run-up to Arena International's Outsourcing in Clinical Trials...

Future oncology: The path to personalised medicine 19 December, 2011 Could the genetic screening of tumour tissues push oncology into the era of personalised patient cancer treatment? Elisabeth Fischer talks to the researchers of the Stratified Cancer Programme...

Take a load off: the age of cloud computing 21 November, 2011 Excessive, unmanageable data may be to blame for low productivity rates in the drug industry. Sarah Blackman looks at how cloud computing can streamline this data to make information...

Trial and error: site selection for clinical studies 19 September, 2011 An often underrated process, site selection is one of the most significant factors for a successful clinical trial. Ahead of Arena International’s Achieve Operational Efficiency in Clinical...

Snapshot H1N1 (swine influenza) – the post-pandemic pipeline 07 September, 2011 Few modern pandemics created as much global furore as the H1N1 swine flu outbreak which struck in 2008. The scale and spread of the outbreak created a very real sense of fear about mutating...

The cholesterol polypill – a global cure-all? 18 August, 2011 Can a new cholesterol polypill open the door to a global mass preventative for cardiovascular diseases? Elisabeth Fischer speaks to Gilbert Thompson, emeritus professor of clinical lipidology...

The Paediatric Medication Controversy 15 July, 2011 The paediatric drugs market is growing rapidly but is a lack of guidance putting children at risk? Elisabeth Fischer sheds some light on the restrictions surrounding paediatric drug...

Parkinson's Disease – Do Novel Targeted Therapies Hold the Cure? 05 July, 2011 Effective treatments for Parkinson's disease are few and far between, but new research into novel therapies hold promise. A growing patient pool, forecasted to triple in the next 50 years,...

Virus-Like Particles: Vaccines of Tomorrow? 22 June, 2011 Virus-like particles represent one of the most exciting new technologies to rapidly produce vaccines. Elisabeth Fischer speaks to industry experts to find out about this cheaper and quicker way...

Contract Chemistry: The Custom Synthesis Market 14 June, 2011 When pharmaceutical companies need compounds for drug development, custom synthesis providers satisfy demand. Chris Lo talks to Onyx Scientific CEO Tony Flinn about the challenges of...